Fulgent Genetics - Leader in Next Generation Sequencing Fulgent is an accredited leader in clinical diagnostic genetic sequencing Fulgent is an accredited leader in clinical diagnostic genetic sequencing Actionable genetic insights for better patient care We offer more than 18,000 tests that can be tailored for your patient
About Us - Fulgent Genetics Fulgent Genetics was the first clinical laboratory to offer copy number variation detection using NGS technology in the United States Today, we continue to offer an unrivaled catalog of genetic testing, including over 18,000+ single gene tests, 900+ rare disease tests, whole genome sequencing, whole genome copy number variation analysis
Beacon Carrier Screening - Fulgent Genetics Backed by Fulgent's Clinical Expertise Our lab is CLIA certified and CAP accredited, meeting the highest standards for patient privacy and test accuracy Our Beacon tests are regularly reviewed and updated based on the latest recommendations and guidance from experts in the field
Fulgent Reports First Quarter 2025 Financial Results EL MONTE, Calif --(BUSINESS WIRE)--May 2, 2025-- Fulgent Genetics, Inc (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its first quarter ended March 31, 2025
Whole Exome - Fulgent Genetics Overview: Whole Exome Sequencing is a patient-centric, phenotype-driven analyses designed to examine coding regions and splice junctions for over 20,000 genes, and report only the variants which are of plausible clinical relevance for your patient
Provider Login - Fulgent Genetics Scheduled Maintenance Saturday, May 6, 2023 Our site will be undergoing scheduled maintenance on May 6 from 12:30PM to 3:00PM (PDT) During this time, access to your portal will not be available
Prenatal Testing - Fulgent Genetics By performing diagnostic testing on a prenatal sample, Fulgent can help identify whether an individual's baby could be at risk for a suspected genetic condition
Fulgent Genetics - Leader in Next Generation Sequencing Fulgent Comprehensive Cancer Panels cover 154 genes associated with potential risk for hereditary cancer syndromes These panels include well-established cancer-related genes as well as candidate genes with newly discovered association with cancer, but may have reduced or unclear risk
Full Comprehensive Cancer Panel - Fulgent Genetics Official gene names change over time Fulgent uses the most up to date gene names based on HUGO Gene Nomenclature Committee (https: www genenames org) recommendations If the gene name on report does not match that of ordered gene, please contact the laboratory and details can be provided
Beacon Carrier Screening Tests - Fulgent Genetics Fulgent Genetics 4399 Santa Anita Ave El Monte, CA 91731 Contact Phone: +1 (626) 350-0537 Fax: +1 (626) 454-1667 info@fulgentgenetics com; About About Us Accreditations Contact Us Careers Products Genes Panels Known Mutation Genomic Testing Hereditary Cancer